Biopharma CEOs on What to Expect at 2021 J.P. Morgan Healthcare Conference

In the months after the closing of the 2020 J.P. Morgan Healthcare conference, the pharmaceutical industry was forced to pivot and adapt to a global pandemic. Despite the challenges faced with lockdowns, social distancing restrictions and developing vaccines and therapeutics for a novel coronavirus, 2020 was still a banner year for the pharmaceutical industry in terms of acquisitions, partnerships and companies that went public.